Latest Legal Activities on Metacel Pharms Llc's Drug Patents

Given below is the list of recent legal activities going on the following drug patents of Metacel Pharms Llc.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 4th Yr, Small Entity	08 Nov, 2023	US10610502
Surcharge for late Payment, Small Entity	08 Nov, 2023	US10610502
Application ready for PDX access by participating foreign offices Critical	07 Apr, 2020	US10610502
Recordation of Patent Grant Mailed Critical	07 Apr, 2020	US10610502
Patent Issue Date Used in PTA Calculation Critical	07 Apr, 2020	US10610502
Email Notification Critical	19 Mar, 2020	US10610502
Issue Notification Mailed Critical	18 Mar, 2020	US10610502
Printer Rush- No mailing	16 Mar, 2020	US10610502
Email Notification Critical	16 Mar, 2020	US10610502
Mail Response to 312 Amendment (PTO-271) Critical	16 Mar, 2020	US10610502
Dispatch to FDC	13 Mar, 2020	US10610502
Application Is Considered Ready for Issue Critical	12 Mar, 2020	US10610502
Response to Amendment under Rule 312 Critical	12 Mar, 2020	US10610502
Pubs Case Remand to TC Critical	10 Mar, 2020	US10610502
Issue Fee Payment Verified Critical	26 Feb, 2020	US10610502

1. Ozobax

Ozobax is protected by 1 patent, which is still active. Check out its patent list below.

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ozobax's drug page